Breakthrough Bounceback Looks Unlikely At US FDA’s CDER, But CBER Is Riding Wave Of RMATs

 
• By Bridget Silverman
Breakthrough wave
Maybe CDER will catch the next wave of the breakthroughs. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Review Pathways

More from Pathways & Standards